Ajovy

Ajovy (Fremanezumab) is a prescription medication used for migraine prevention. This intravenous treatment is designed to reduce the frequency of migraine episodes in eligible patients.

Ajovy is primarily used for the preventive treatment of migraines. It is intended for patients who experience frequent migraine episodes and may benefit from intravenous administration. The medication works by targeting specific pathways involved in migraine pathogenesis, aiming to reduce the occurrence of these debilitating headaches.

Common effects of Ajovy may include injection site reactions, such as redness, pain, or swelling. Some patients might experience fatigue, upper respiratory tract infections, or mild flu-like symptoms. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Ajovy should be administered under the supervision of a healthcare professional. Patients with a history of severe hypersensitivity reactions to Fremanezumab or any of its components should avoid using this medication. It is important to disclose all current medications and health conditions to your healthcare provider before starting treatment.

Ajovy may interact with other medications, particularly those that affect the immune system or blood clotting. It is advisable to avoid alcohol while using this medication, as it may exacerbate certain side effects. Always consult with a healthcare provider regarding potential drug interactions before starting Ajovy.